Abbott’s ARCHITECT Syphilis TP has received US FDA clearance! The assay is intended to be used as an initial diagnostic test or in conjunction with a nontreponemal laboratory test and clinical findings to aid in the diagnosis of syphilis infection.
The prevalence of syphilis has doubled since 2005 resulting in labor increases and burdens to the lab. Treponemal assays like ARCHITECT Syphilis TP are automated reducing labor cost, provide objective interpretation of results and have fewer false positives than nontreponemal assays.
To learn more about and/or to order ARCHITECT Syphilis TP assay please contact your Abbott Sales Representative.
Warning: The ARCHITECT Syphilis TP assay is not intended for use in screening blood, plasma, or tissue donors.